The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Colorectal cancer molecular biology moves into clinical practice
Open accessAbstract
The promise of personalised medicine is now a clinical reality, with colorectal cancer genetics at the forefront of this next major advance in clinical medicine. This is no more evident than in the recent advances in testing of colorectal cancers for specific molecular alterations in order to guide treatment with the monoclonal antibody therapies cetuximab and panitumumab, which target the epidermal growth factor receptor. In this review, genetic mechanisms of colorectal cancer and how these alterations relate to emerging biomarkers for early detection and risk stratification (diagnostic markers), prognosis (prognostic markers) and the prediction of treatment responses (predictive markers) are examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Lièvre, A., Bachet, J.-B., Le Corre, D., Boige, V., Landi, B., Emile, J.-F., Côté, J.-F., Tomasic, G., Penna, C., Ducreux, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0191 · Cited by 2,229
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160 · cited 1×
“gene itself. Early studies that focused on EGFR overexpression assessed by immunohistochemistry did not show a consistent relationship with treatment response, in part because of lack of standardisation of the assay, which were based on either immunostaining, fluorescent in situ hybridisation (FISH) or quantitative RT…”
BackgroundEGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Van Cutsem, E., Peeters, M., Siena, S., Humblet, Y., Hendlisz, A., Neyns, B., Canon, J.-L., Van Laethem, J.-L., Maurel, J., Richardson, G., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1620 · Cited by 1,979
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Bokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8397 · Cited by 1,636
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408 · cited 1×
“Also of interest, it is now recognised that a strategy that relies on clinical criteria alone for the diagnosis of individuals at risk for Lynch syndrome underdiagnoses this syndrome.(69) In light of the substantial effect of a missed diagnosis on an individual’s likelihood of developing cancer in the future, a strate…”
BackgroundRAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156 · cited 1×
“and [KRAS-mutant] patients should not receive anti-EGFR antibody therapy ’.(3) Similarly, the National Comprehensive Cancer Network (NCCN) guidelines require evidence ofWT KRAS prior to cetuximab or panitumumab treatment in all metastatic colorectal cancer settings.”
BackgroundSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
Self-citationMolecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Benvenuti, S., Sartore-Bianchi, A., Di Nicolantonio, F., Zanon, C., Moroni, M., Veronese, S., Siena, S., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4158 · Cited by 830
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Bardelli, A., & Siena, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6116 · Cited by 746
Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2466 · Cited by 739
Di Fiore, F., Blanchard, F., Charbonnier, F., Le Pessot, F., Lamy, A., Galais, M. P., Bastit, L., Killian, A., Sesboüé, R., Tuech, J. J., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603685 · Cited by 734
Genetic prognostic and predictive markers in colorectal cancer
Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I., & Kerr, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2645 · Cited by 705
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R.-A., Rabinovitch, P. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1768 · Cited by 696
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y.-J., Choti, M. A., Cooper, H. S., Covey, A., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0056 · Cited by 683
Laurent-Puig, P., Cayre, A., Manceau, G., Buc, E., Bachet, J.-B., Lecomte, T., Rougier, P., Lievre, A., Landi, B., Boige, V., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6796 · Cited by 673
Smith, R. A., Cokkinides, V., Brooks, D., Saslow, D., & Brawley, O. W. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20063 · Cited by 660
Shia, J. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080031 · Cited by 643
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Douillard, J. Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu141 · Cited by 606
Mutations in a signalling pathway
Parsons, D. W., Wang, T.-L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599
Loupakis, F., Ruzzo, A., Cremolini, C., Vincenzi, B., Salvatore, L., Santini, D., Masi, G., Stasi, I., Canestrari, E., Rulli, E., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605177 · Cited by 564
Richman, S. D., Seymour, M. T., Chambers, P., Elliott, F., Daly, C. L., Meade, A. M., Taylor, G., Barrett, J. H., & Quirke, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4295 · Cited by 560
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
Smith, R. A., Cokkinides, V., & Brawley, O. W. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20008 · Cited by 495
UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters
Hoskins, J. M., Goldberg, R. M., Qu, P., Ibrahim, J. G., & McLeod, H. L. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm115 · Cited by 469
Jhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y.-H., Byun, D.-S., Nasser, S., Arango, D., Shin, J., Klampfer, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5659 · Cited by 460
Saltz, L. B., Niedzwiecki, D., Hollis, D., Goldberg, R. M., Hantel, A., Thomas, J. P., Fields, A. L. A., & Mayer, R. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2144 · Cited by 449
BRAF Mutation in Metastatic Colorectal Cancer
Tol, J., Nagtegaal, I. D., & Punt, C. J. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0904160 · Cited by 445
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
Chung, D. C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16507 · Cited by 414
Schwab, M., Zanger, U. M., Marx, C., Schaeffeler, E., Klein, K., Dippon, J., Kerb, R., Blievernicht, J., Fischer, J., Hofmann, U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4182 · Cited by 393
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
Self-citationJacobs, B., De Roock, W., Piessevaux, H., Van Oirbeek, R., Biesmans, B., De Schutter, J., Fieuws, S., Vandesompele, J., Peeters, M., Van Laethem, J.-L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3744 · Cited by 368
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
Walther, A., Houlston, R., & Tomlinson, I. (2008) · Gut · doi:10.1136/gut.2007.135004 · Cited by 368
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Genomic instability and colon cancer
Grady, W. M. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025861527711 · Cited by 353
Self-citationKim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 342
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
Domingo, E., Laiho, P., Ollikainen, M., Pinto, M., Wang, L., French, A. J., Westra, J., Frebourg, T., Espín, E., Armengol, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020651 · Cited by 339
Rodriguez, J., Frigola, J., Vendrell, E., Risques, R.-A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capellà, G., Ribas, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0293 · Cited by 335
KRAS Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Huang, L. (2009) · Journal of Evidence-Based Medicine · Cited by 330
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
Hermsen, M., Postma, C., Baak, J., Weiss, M., Rapallo, A., Sciutto, A., Roemen, G., Arends, J., Williams, R., Giaretti, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36051 · Cited by 328
Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., Chan, A. T., Engelman, J. A., Kraft, P., Cantley, L. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6544 · Cited by 323
Nosho, K., Irahara, N., Shima, K., Kure, S., Kirkner, G. J., Schernhammer, E. S., Hazra, A., Hunter, D. J., Quackenbush, J., Spiegelman, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003698 · Cited by 311
Prenen, H., De Schutter, J., Jacobs, B., De Roock, W., Biesmans, B., Claes, B., Lambrechts, D., Van Cutsem, E., & Tejpar, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2961 · Cited by 291
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Barault, L., Charon-Barra, C., Jooste, V., de la Vega, M. F., Martin, L., Roignot, P., Rat, P., Bouvier, A.-M., Laurent-Puig, P., Faivre, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1171 · Cited by 286
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang, L., Cunningham, J. M., Winters, J. L., Guenther, J. C., French, A. J., Boardman, L. A., Burgart, L. J., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (2003) · PubMed · Cited by 282
Serrated Polyps and Colorectal Cancer: New Pathway to Malignancy
Noffsinger, A. E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092317 · Cited by 282
Braun, M. S., Richman, S. D., Quirke, P., Daly, C., Adlard, J. W., Elliott, F., Barrett, J. H., Selby, P., Meade, A. M., Stephens, R. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5580 · Cited by 280
Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N. (2004) · Disease Markers · doi:10.1155/2004/136734 · Cited by 276
Sartore-Bianchi, A., Di Nicolantonio, F., Nichelatti, M., Molinari, F., De Dosso, S., Saletti, P., Martini, M., Cipani, T., Marrapese, G., Mazzucchelli, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007287 · Cited by 259
Grady, W. M., Rajput, A., Myeroff, L. L., Liu, D. F., Kwon, K., Willis, J. E., & Markowitz, S. D. (1998) · PubMed · Cited by 244
Self-citationImproved Fecal DNA Test for Colorectal Cancer Screening
Itzkowitz, S. H., Jandorf, L., Brand, R., Rabeneck, L., Schroy, P. C., Sontag, S., Johnson, D., Skoletsky, J., Durkee, K., Markowitz, S., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.006 · Cited by 243
Fallik, D., Borrini, F., Boige, V., Viguier, J., Jacob, S., Miquel, C., Sabourin, J., Ducreux, M. P., & Praz, F. (2003) · PubMed · Cited by 232
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Bordonaba, F. A. M. (2009) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)79091-1 · Cited by 230
Samowitz, W. S., Powers, M. D., Spirio, L. N., Nollet, F., Roy, F. M. V., & Slattery, M. L. (1999) · PubMed · Cited by 225
Stool screening for colorectal cancer: Molecular approaches
Osborn, N. K., & Ahlquist, D. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.041 · Cited by 216
Zhang, L. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080062 · Cited by 213
Miyaki, M., Iijima, T., Kimura, J., Yasuno, M., Mori, T., Hayashi, Y. K., Koike, M., Shitara, N., Iwama∥, T., & Kuroki, T. (1999) · PubMed · Cited by 201
Mutations of KRAS and BRAF in Primary and Matched Metastatic Sites of Colorectal Cancer
Artale, S., Sartore-Bianchi, A., Veronese, S. M., Gambi, V., Sarnataro, C. S., Gambacorta, M., Lauricella, C., & Siena, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7286 · Cited by 192
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Shia, J., Klimstra, D. S., Li, A. R., Qin, J., Saltz, L., Teruya-Feldstein, J., Akram, M., Chung, K. Y., Yao, D., Paty, P. B., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800417 · Cited by 163
Hyperplastic polyps and colorectal cancer: is there a link?
Jass, J. R. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00284-2 · Cited by 163
A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection
Itzkowitz, S., Brand, R., Jandorf, L., Durkee, K., Millholland, J., Rabeneck, L., Schroy, P. C., Sontag, S., Johnson, D., Markowitz, S., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02088.x · Cited by 161
Hinoue, T., Weisenberger, D. J., Pan, F., Campan, M., Kim, M.-J., Young, J. P., Whitehall, V., Leggett, B., & Laird, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008357 · Cited by 159
Palomaki, G. E., Bradley, L., Douglas, M. P., Kolor, K., & Dotson, W. D. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818efd77 · Cited by 153
Molecular Detection of Colorectal Neoplasia
Ahlquist, D. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.055 · Cited by 139
Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
Carethers, J. M., Hawn, M. T., Greenson, J. K., Hitchcock, C. L., & Boland, C. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70424-x · Cited by 131
Baudhuin, L. M., Burgart, L. J., Leontovich, O. N., & Thibodeau, S. N. (2005) · Familial Cancer · doi:10.1007/s10689-004-1447-6 · Cited by 129
Matsuzaki, K., Deng, G., Tanaka, H., Kakar, S., Miura, S., & Kim, Y. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0859 · Cited by 123
Serrated Pathway and APC (Conventional)-Type Colorectal Polyps
Goldstein, N. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/87bd0c6ucgug236j · Cited by 121
Ogino, S., Nosho, K., Irahara, N., Shima, K., Baba, Y., Kirkner, G. J., Meyerhardt, J. A., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8858 · Cited by 121
Liang, J., Huang, K., Lai, H., Lee, P., Cheng, Y., Hsu, H., Cheng, A., Hsu, C., Yeh, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10643 · Cited by 120
Oncogenic mutations as predictive factors in colorectal cancer
Lièvre, A., Blons, H., & Laurent-Puig, P. (2010) · Oncogene · doi:10.1038/onc.2010.89 · Cited by 117
Zlobec, I., Kovac, M. B., Erzberger, P., Molinari, F., Bihl, M., Rufle, A., Foerster, A., Frattini, M., Terracciano, L., Heinimann, K., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25265 · Cited by 114
SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer
Alhopuro, P., Alazzouzi, H., Sammalkorpi, H., Dávalos, V., Salovaara, R., Hemminki, A., Järvinen, H., Mecklin, J., Schwartz, S., Aaltonen, L. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0244 · Cited by 111
Bettstetter, M., Dechant, S., Ruemmele, P., Grabowski, M., Keller, G., Holinski‐Feder, E., Hartmann, A., Hofstaedter, F., & Dietmaier, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3064 · Cited by 107
Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study
Razis, E. D., Briasoulis, E. C., Vrettou, E., Skarlos, D. V., Papamichael, D., Kostopoulos, I. S., Samantas, E., Xanthakis, I., Bobos, M., Galanidi, E., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-234 · Cited by 97
Roth, A., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Archive ouverte UNIGE (University of Geneva) · Cited by 95
Sargent, D. J., Marsoni, S., Thibodeau, S. N., Labianca, R., Hamilton, S. R., Torri, V., Monges, G., Ribic, C. M., Grothey, A. A., & Gallinger, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4008 · Cited by 91
Douillard, J., Siena, S., Cassidy, J., Tabernero, J. M., Burkes, R. L., Barugel, M. E., Humblet, Y., Cunningham, D., Wolf, M., & Gansert, J. L. (2009) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(09)72039-7 · Cited by 89
Chemotherapeutic implications in microsatellite unstable colorectal cancer1
Jo, W., & Carethers, J. M. (2006) · Cancer Biomarkers · doi:10.3233/cbm-2006-21-206 · Cited by 87
Iacopetta, B. J., Kawakami, K., & Watanabe, T. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0854-3 · Cited by 80
Boulay, J.-L., Mild, G., Lowy, A. J., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600511 · Cited by 79
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors
Lubomierski, N., Plotz, G., Wormek, M., Engels, K., Kriener, S., Trojan, J., Jüngling, B., Zeuzem, S., & Raedle, J. (2005) · Cancer · doi:10.1002/cncr.21266 · Cited by 70
Zauber, P., Sabbath-Solitare, M., Marotta, S. P., & Bishop, D. T. (2003) · Molecular Pathology · doi:10.1136/mp.56.3.137 · Cited by 60
Systemic therapy for colorectal cancer
Štabuc, B. (2003) · Archive of oncology · doi:10.2298/aoo0304255s · Cited by 57
Chittenden, T. W., Howe, E., Culhane, A. C., Sultana, R., Taylor, J. M., Holmes, C. C., & Quackenbush, J. F. (2008) · Genomics · doi:10.1016/j.ygeno.2008.03.002 · Cited by 54
Correction: Prediction of Response to Cetuximab
(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-16-cor1 · Cited by 54
Deacu, E., Mori, Y., Sato, F., Yin, J., Olaru, A., Sterian, A., Xu, Y. H., Wang, S., Schulmann, K., Berki, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2082 · Cited by 49
Baker, K., Zhang, Y., Jin, C., & Jass, J. R. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016600 · Cited by 46
Danielsen, S. A., Lind, G. E., Bjørnslett, M., Meling, G. I., Rognum, T. O., Heim, S., & Lothe, R. A. (2008) · Human Mutation · doi:10.1002/humu.20860 · Cited by 42
Tanaka, T., Watanabe, T., Kazama, Y., Tanaka, J., Kanazawa, T., Kazama, S., & Nagawa, H. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20896 · Cited by 35
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors
Vilar, E., Balmañà, J., & Espín, E. (2006) · Cancer · doi:10.1002/cncr.21902 · Cited by 7
Cited by
Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F., Cathomas, G., Dawson, H., El Zimaity, H., Fléjou, J.-F., Hansen, T. P., Hartmann, A., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.46 · Cited by 1,156
Bachmayr-Heyda, A., Reiner, A. T., Auer, K., Sukhbaatar, N., Aust, S., Bachleitner-Hofmann, T., Mesteri, I., Grunt, T. W., Zeillinger, R., & Pils, D. (2015) · Scientific Reports · doi:10.1038/srep08057 · Cited by 736
Epigenetics and colorectal cancer
Lao, V. V., & Grady, W. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.173 · Cited by 736
Self-citationClinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F., El Messaoudi, S., Mollevi, C., Lopez-Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 678
Yamauchi, M., Morikawa, T., Kuchiba, A., Imamura, Y., Qian, Z. R., Nishihara, R., Liao, X., Waldron, L., Hoshida, Y., Huttenhower, C., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300865 · Cited by 606
Metadata
- Authors
- Pritchard, C. C., & Grady, W. M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-10-04
- Volume
- 60
- Issue
- 1
- Pages
- 116-129
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2141285914
- Cited by
- 344
- References
- 120
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.